Tomographic fluorescence mapping of tumor targets

Area of Science:

• Biomedical imaging
• Molecular biology
• Preclinical research

Background:

• Robust in vivo imaging of molecular targets is crucial for biology and medicine.
• Existing methods may lack the speed or sensitivity for dynamic biological processes.

Purpose of the Study:

• To present and validate a quantitative, three-dimensional fluorescence-mediated tomographic technique (FMT) for in vivo imaging.
• To demonstrate FMT's utility in assessing tumor angiogenesis and therapeutic response.
• To showcase FMT's capability for simultaneous multichannel measurements.

Main Methods:

• Utilized a quantitative, three-dimensional fluorescence-mediated tomographic technique (FMT).
• Employed fluorochrome-based affinity tags for measurements in live xenograft models.
• Validated sensitivity using an anti-vascular endothelial growth factor antibody to quantify tumor angiogenesis.

Main Results:

• Demonstrated FMT's sensitivity in quantitating tumor angiogenesis and its modulation by therapy.
• Showcased feasibility of simultaneous multichannel measurements of distinct biological phenomena (e.g., receptor tyrosine kinase expression, angiogenesis).
• Confirmed that FMT allows serial measurements with short imaging times within the same live animal.

Conclusions:

• FMT is a valuable tool for rapid, quantitative in vivo imaging of molecular targets and biological processes.
• The technique facilitates sensitive assessment of tumor angiogenesis and therapeutic efficacy.
• FMT enables simultaneous monitoring of multiple biological phenomena, offering comprehensive insights in preclinical models.